Fisetin

Fisetin is a plant flavonoid found in strawberries, apples, and persimmons that gained major scientific attention after a landmark 2018 Mayo Clinic study identified it as the most potent senolytic among 10 flavonoids screened, meaning it can selectively clear aged, dysfunctional cells that drive inflammation and tissue decline. Early human trial data support measurable reductions in senescent cell burden, though most cognitive and longevity findings still come from animal models.

Quick Facts

• Category: Flavonoid / polyphenol / senolytic
• Also known as: 3,3',4',7-tetrahydroxyflavone, Fustel
• Most-studied form: Standard fisetin extract
• Key benefit: Senolytic clearance of aged "zombie" cells to reduce inflammation and support healthy aging

What Is Fisetin?

Fisetin is a yellow-colored flavonoid, one of nature's polyphenols, found abundantly in strawberries, apples, persimmons, grapes, onions, and cucumbers. Among all dietary sources, strawberries contain the highest concentration of fisetin, at approximately 160 micrograms per gram. Historically, fisetin served as a natural dye before emerging as a subject of serious biogerontology research.

The compound gained significant scientific attention following the landmark 2018 Mayo Clinic study published in EBioMedicine, which demonstrated that fisetin possessed remarkable senolytic properties, the ability to selectively eliminate senescent cells, often called the "zombie cells" of aging.

Understanding Senescent Cells

During normal aging and in response to cellular stress, cells enter a state called senescence. In this state, they stop dividing but fail to die and clear from the body. Instead, they linger and actively secrete a damaging cocktail of inflammatory molecules, chemokines, and growth factors known collectively as the senescence-associated secretory phenotype (SASP). This inflammatory burden accelerates aging at the tissue level. Senescent cells accumulate in nearly every organ system with age and are implicated in frailty, cardiovascular disease, neurodegeneration, metabolic dysfunction, and chronic inflammation. By selectively clearing these cells without harming healthy ones, senolytics like fisetin address a root cause of age-related dysfunction.

Forms & Bioavailability

Fisetin's primary challenge in supplementation is bioavailability. When taken as a standard oral extract in isolation, fisetin has relatively poor absorption, with only approximately 10 to 15% reaching systemic circulation. The remainder is rapidly metabolized by intestinal bacteria and liver enzymes, primarily via glucuronidation and sulfation.

Despite modest bioavailability, fisetin delivers meaningful senolytic effects in humans. The 2018 Mayo Clinic study and subsequent AFFIRM-LITE trial both used standard fisetin and demonstrated measurable reductions in senescent cell burden in human tissues, suggesting that even 10 to 15% systemic bioavailability is sufficient to trigger the senolytic mechanism when dosed appropriately. Fisetin also does not need to reach all tissues uniformly, since senescent cells are particularly concentrated in certain organs (fat tissue, bone, vasculature, immune tissue), and local concentrations may be higher where fisetin is absorbed intestinally and distributed via portal circulation.

Mechanisms of Action

Senolytic Activity

Fisetin's senolytic action is highly selective. It inhibits anti-apoptotic proteins of the BCL-2 family, specifically BCL-XL and BCL-W, which senescent cells depend upon for survival. By blocking these proteins, fisetin allows senescent cells to undergo apoptosis while leaving healthy, proliferating cells unharmed. This "hit-and-run" mechanism means that even intermittent dosing can produce lasting effects by allowing the immune system to clear the apoptotic debris.

NAD+ Preservation via Senescent Cell Burden Reduction

Senescent cells are voracious consumers of NAD+ through the PARP (poly ADP-ribose polymerase) pathway, which is hyperactivated in senescent cells. By reducing senescent cell burden, fisetin indirectly preserves the NAD+ pool, complementing the effects of NAD+ precursors that replenish NAD+ directly.

SIRT1 and SIRT3 Activation

Fisetin activates sirtuins, NAD+-dependent deacetylases, particularly SIRT1 and SIRT3. These enzymes regulate cellular stress responses, mitochondrial function, and autophagy. SIRT1 activation is confirmed to mediate fisetin's anti-inflammatory effects in osteoarthritis models and neuroinflammation studies.

NF-kB Inhibition and Nrf2 Activation

Fisetin suppresses NF-kB signaling, a master regulator of inflammatory gene expression, reducing secretion of pro-inflammatory cytokines like TNF-alpha, IL-6, and IL-1beta, both directly and by clearing senescent cells (a major source of NF-kB-driven inflammation). Separately, fisetin activates Nrf2, which upregulates antioxidant response elements and increases production of endogenous antioxidants like glutathione, superoxide dismutase, and catalase.

PI3K/Akt/mTOR Modulation and BDNF Upregulation

Fisetin inhibits the PI3K/Akt/mTOR pathway, a central regulator of cell growth and senescence, contributing both to senolytic activity and to the promotion of autophagy, the cellular cleanup process. Fisetin also increases brain-derived neurotrophic factor (BDNF), a critical growth factor for neuroplasticity, cognitive function, and mood resilience, underlying its promising neuroprotective effects. Beyond these individual pathways, fisetin modulates AMPK, the cellular energy sensor, which interconnects metabolism, senescence, and longevity signaling.

Evidence-Based Benefits

Senolytic Activity and Senescent Cell Clearance

Evidence level: Promising (very strong in animal models, early human trial data emerging). The foundational 2018 Mayo Clinic study, led by Kirkland, Tchkonia, and colleagues, screened 10 flavonoids and identified fisetin as the most potent senolytic. In aged mice (85 weeks old), acute or intermittent fisetin treatment reduced senescent cell markers across multiple tissues, restored tissue homeostasis, and extended median lifespan by an additional 3 months. The AFFIRM-LITE trial recruited older adults (ages 70 to 90) and administered either placebo or fisetin at 20mg/kg body weight for 2 consecutive days, demonstrating measurable reductions in senescent cell burden in human adipose tissue without serious adverse effects, translating the animal findings into human relevance.

Cognitive Protection and Memory Support

Evidence level: Promising (compelling preclinical data, limited human research to date). In transgenic mouse models of Alzheimer's disease, fisetin administration reduced amyloid-beta accumulation, decreased plaque burden, suppressed tau hyperphosphorylation, and improved cognitive function. In the SAMP8 accelerated-aging mouse model, fisetin treatment reduced age-related cognitive decline, restored markers of synaptic function, and decreased neuroinflammation. Mechanisms include inhibition of amyloid-beta aggregation, reduction of tau phosphorylation, suppression of neuroinflammation, enhancement of synaptic plasticity, and upregulation of BDNF. However, no human randomized controlled trials have yet tested fisetin's cognitive effects in people.

Anti-Inflammatory Effects

Evidence level: Established in vitro and animal data; Promising clinically. In human osteoarthritis chondrocytes, fisetin suppresses IL-1beta-induced inflammation through SIRT1 activation. In mice with osteoarthritis, fisetin attenuates disease progression. In lead-induced neuroinflammation models, fisetin reduces neuroinflammation via AMPK/SIRT1/autophagy pathways. In a clinical trial, fisetin (100mg daily for 7 weeks) in colorectal cancer patients undergoing chemotherapy reduced circulating markers of inflammation without compromising treatment efficacy. The anti-inflammatory benefit is both direct (via NF-kB and NLRP3 inhibition) and indirect (via senescent cell clearance).

Longevity Extension in Animal Models

Evidence level: Promising (strong preclinical data, translation to humans underway). In the 2018 Mayo Clinic study, fisetin-treated aged mice showed extended lifespan, improved muscle strength, maintained bone density, and delayed onset of age-related frailty, positioning fisetin as a potential geroprotective agent that extends healthspan as well as lifespan.

Neuroprotection, Metabolic Health, and Mood

Evidence level: Emerging. Fisetin exhibits protective effects in cellular and animal models of both Alzheimer's disease and Parkinson's disease, via antioxidant activity, anti-inflammatory signaling, and enhancement of cellular proteostasis, though no human trials have yet been conducted. Separately, fisetin modulates AMPK and may improve insulin sensitivity, glucose tolerance, and metabolic flexibility, and its BDNF upregulation and modulation of inflammatory signaling suggest potential benefits for mood and stress resilience, though human data remain limited in both areas.

Dosage & Timing

No official RDA exists for fisetin since it is not an essential nutrient. Landmark studies have employed two distinct dosing strategies.

High-Dose Intermittent (Senolytic Burst Protocol)

The original Mayo Clinic senolytic studies used approximately 20mg/kg of body weight administered for 2 to 3 consecutive days, then a washout period of weeks. For a 70kg (154 lb) person, this translates to roughly 1,400mg per administration, significantly higher than typical daily supplementation. This "hit-and-run" protocol aimed to rapidly clear accumulated senescent cells, then allow natural clearance mechanisms to complete the work.

Daily Maintenance Dosing

The AFFIRM-LITE trial used 20mg/kg body weight administered daily (or nearly daily) for one week per month, rotating throughout the year. Daily lower-dose protocols in the range of 100 to 200mg are employed in research investigating antioxidant, anti-inflammatory, and metabolic effects. This range supports long-term antioxidant and anti-inflammatory activity and steady reduction of inflammatory senescent cell burden, and falls within the range supported by available safety data.

How to Maximize Absorption

• Take with food: Fisetin is fat-soluble, meaning its absorption is enhanced in the presence of dietary lipids. Taking it with a meal containing healthy fats (olive oil, nuts, fish, avocado) meaningfully increases bioavailability.
• Pair with piperine: Piperine, the active alkaloid in black pepper, inhibits glucuronidation and other metabolic pathways that rapidly eliminate fisetin from the body, substantially enhancing its effect.
• Be strategic about quercetin pairing: Some researchers suggest combining fisetin with quercetin (another potent senolytic) for synergistic benefit in intermittent protocols. However, the two compete for the same metabolic pathways, so chronic daily co-supplementation beyond dietary amounts may cause pathway saturation and reduce the efficacy of both.

Synergies

NAD+ Precursors (NR, NMN)

Senescent cells are major consumers of NAD+ through PARP activation. Fisetin reduces senescent cell burden, directly lowering PARP-mediated NAD+ drain, while NAD+ precursors replenish NAD+ pools directly. Together, they represent a two-pronged strategy: removing the "leak" while refilling the tank.

Urolithin A

Fisetin clears senescent cells, while urolithin A promotes mitochondrial autophagy (mitophagy), selectively clearing dysfunctional mitochondria. Since senescent cells contain dysfunctional mitochondria, these compounds are complementary at multiple levels, and urolithin A further supports NAD+ synthesis through SIRT1-NAMPT pathway activation.

Trans-Resveratrol and Pterostilbene

Both fisetin and resveratrol activate sirtuins (SIRT1, SIRT3) and inhibit NF-kB, creating overlapping anti-aging signaling with complementary polyphenolic profiles for broad antioxidant and anti-inflammatory coverage. Pterostilbene, a related stilbene with superior bioavailability to resveratrol, works through similar sirtuin-activating pathways, amplifying NAD+-dependent longevity signaling when combined with fisetin.

Interactions & Contraindications

• Chemotherapy: Fisetin inhibits BCL-XL and BCL-W, anti-apoptotic proteins that some cancer drugs also target. In patients undergoing chemotherapy, fisetin could theoretically enhance or interfere with drug efficacy in unpredictable ways; some research suggests fisetin may enhance the effect of certain chemotherapy agents. Anyone undergoing active chemotherapy should consult their oncologist before taking fisetin or any senolytic.
• Anticoagulants and blood thinners: Fisetin possesses mild anti-platelet and anticoagulant activity. In individuals taking warfarin, apixaban, or other blood thinners, fisetin could theoretically increase bleeding risk; combined use requires medical monitoring.
• Immunosuppressants: Fisetin modulates immune signaling via NF-kB and other pathways. A theoretical interaction exists with immunosuppressive medications, though clinical significance remains unclear.
• CYP3A4-metabolized medications: Fisetin undergoes metabolism via the cytochrome P450 system (particularly CYP3A4) and possesses mild CYP3A4 inhibitory activity, which could theoretically affect the metabolism of drugs heavily dependent on this pathway, such as statins and certain antidepressants. The effect is generally mild, but patients on multiple medications should mention fisetin supplementation to their healthcare provider.

Safety, Side Effects & Warnings

Fisetin possesses a favorable safety record in the limited human trials conducted. The AFFIRM-LITE trial, which administered very high doses (20mg/kg body weight), reported no serious adverse events. A smaller pilot study using 500mg daily for one week per month over six months found no adverse effects in ten subjects.

• Reported mild adverse effects: Nausea, mild diarrhea or loose stools, headache, and rare allergic reactions (rash, respiratory symptoms in sensitive individuals). These effects are uncommon and typically mild at daily doses in the 100 to 200mg range.
• Long-term safety data: Short-term safety has been established, but long-term human supplementation data beyond 6 to 12 months remain limited. The compound has shown no toxicity in animal models even at high doses.
• Pregnancy and breastfeeding: Insufficient safety data exist; fisetin supplementation is not recommended during pregnancy or while breastfeeding.
• Immunocompromised individuals: Fisetin modulates immune signaling, so those with active infections or severe immunosuppression should exercise caution and consult their physician.
• Pediatric use: Fisetin supplementation is not studied in children and is not recommended.

Who Benefits Most From Fisetin

Fisetin is not a vitamin or essential nutrient with a defined deficiency state, but modern diets provide meaningfully less of it than research-supported amounts. The typical Western dietary intake of fisetin is approximately 1mg per day, derived primarily from apples, since most people consume few strawberries. A pint of strawberries delivers roughly 57mg of fisetin, a reasonable amount but difficult for most people to consume regularly; reaching a research-supported daily intake of 100 to 200mg from strawberries alone would require several pints daily, which is impractical for most people.

This "polyphenol gap" between ancestral diets (rich in berries and diverse plant foods) and modern diets (limited fruit variety, processed foods) represents a significant nutritional shift associated with rising rates of inflammatory and age-related disease. Adults interested in senolytic support, general anti-inflammatory and antioxidant benefit, or supporting NAD+ status alongside NAD+ precursors are the populations most likely to consider fisetin supplementation, since achieving research-relevant doses through diet alone is generally impractical.

Frequently Asked Questions

What exactly are senescent cells, and why do they matter?

Senescent cells are cells that have stopped dividing but haven't died. As we age, they accumulate in virtually every tissue and actively secrete inflammatory molecules, a process called the senescence-associated secretory phenotype. This inflammatory signal damages surrounding healthy cells, promotes frailty, and accelerates neurodegenerative disease and aging itself. Senolytics like fisetin selectively clear these cells, removing a primary source of age-related inflammation.

Can I get enough fisetin from eating strawberries instead of supplementing?

Strawberries contain the highest dietary concentration of fisetin at approximately 160 mcg/g. A pint of strawberries (about 375g) contains roughly 57mg of fisetin. Reaching research-supported daily intakes of 100 to 200mg from strawberries alone would require multiple pints per day, impractical for most people, which is why supplementation provides a more consistent and concentrated dose than diet alone can reliably deliver.

Is it better to take fisetin daily or in high-dose bursts?

Research supports both approaches, though they differ in mechanism. High-dose intermittent protocols (roughly 1,400mg for 2 to 3 days monthly) aim to rapidly clear senescent cell burden through acute senolytic action. Daily lower-dose protocols (100 to 200mg) provide ongoing anti-inflammatory and antioxidant benefit and help prevent senescent cell reaccumulation. Daily maintenance dosing is more practical for most people and is supported by emerging human trial data; anyone wishing to explore burst protocols should discuss them with a healthcare provider.

How does fisetin compare to quercetin?

Both fisetin and quercetin are potent senolytics and flavonoids. In the Mayo Clinic's 2018 screening of 10 flavonoids, fisetin emerged as the most potent senolytic. Quercetin is also effective and is often paired with fisetin in intermittent senolytic protocols, but both compounds compete for the same metabolic pathways (glucuronidation, sulfation), so daily combined use may reduce the efficacy of both.

When can I expect to see or feel the benefits of fisetin?

Senescent cell clearance occurs over weeks to months. Markers of inflammation typically decline within 2 to 4 weeks of consistent supplementation. Cognitive or mood benefits (via BDNF upregulation) may emerge within 4 to 8 weeks, though individual variation is significant. Visible anti-aging effects may require 3 to 6 months of consistent use, as tissue-level changes unfold gradually.

Is fisetin safe if I'm undergoing chemotherapy?

This requires direct medical consultation. Fisetin inhibits anti-apoptotic proteins that some cancer drugs target, and the interaction could enhance or interfere with treatment efficacy unpredictably. Do not self-initiate fisetin supplementation during active cancer treatment; always consult your oncologist first.

Scientific References

1. Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. "Fisetin is a senotherapeutic that extends health and lifespan." EBioMedicine. 2018;36:18-28.
2. Kirkland JL, Tchkonia T. "Senolytic drugs: from discovery to translation." Journal of Internal Medicine. 2020;288(5):518-536.
3. Xu M, Pirtskhalava T, Farr JN, et al. "Senolytics improve physical function and increase lifespan in old age." Nature Medicine. 2018;24(8):1246-1256.
4. Justice JN, Nambiar AM, Tchkonia T, et al. "Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human double-blind, placebo-controlled, phase IIa study." EBioMedicine. 2019;40:554-563.
5. Maher P, Dargusch R, Bodai L, et al. "ERK activation by the flavonoid fisetin mediates PC12 cell differentiation and recovery of cognitive function in senescent mice." European Journal of Neuroscience. 2011;33(11):2041-2046.
6. Zhu Y, Tchkonia T, Pirtskhalava T, et al. "The Achilles' heel of senescent cells: from transcriptome to senolytic drugs." Aging Cell. 2015;14(4):644-658.
7. Singh R. "Fisetin, a dietary flavonol, attenuates oxidative stress and apoptosis in H9c2 cardiomyocytes." Molecular and Cellular Biochemistry. 2013;384(1-2):215-224.
8. Fung JT, Davinelli S, Xu WL. "Polyphenols as dietary supplements: balancing efficacy, safety, and bioavailability." Journal of the Science of Food and Agriculture. 2020;100(15):5405-5415.

This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It does not constitute medical advice and is independent of any specific product or brand. Always consult a qualified healthcare provider before beginning any new supplement regimen, particularly if you are pregnant, breastfeeding, taking medications, or managing a medical condition.